The findings show that resveratrol therapy reduces the activity of two major tau kinases in AD, CDK5, and GSK3β, in the cortex of SAMP8 mice, and that tau phosphorylation in Ser396 is prevented by inhibiting these tau kinases. This evidence concerns the gene CDK5 and Alzheimer disease.